Literature DB >> 3889248

Long-term sequelae of group B streptococcal meningitis in infants.

M S Edwards, M A Rench, A A Haffar, M A Murphy, M M Desmond, C J Baker.   

Abstract

The long-term outcome and admission features predictive of outcome were determined for 61 patients with group B streptococcal meningitis treated between 1974 and 1979. Infection was rapidly fatal in 13 patients (21%). Among the 48 survivors, 38 (79%) 3 years of age or older were available for comprehensive evaluation. Excluding five who had died before age 3 years, the mean age at evaluation was 6.0 years (range 3.3 to 9.0 years). Among survivors, 11 (29%) had severe neurologic sequelae, eight (21%) had mild to moderate deficits, and 19 (50%) were functioning normally. Analysis of predictive features revealed a significant risk of death or severe impairment among infants who at hospital admission were comatose or semicomatose, had decreased perfusion, total peripheral WBC less than 5,000/mm3, absolute neutrophil count less than 1000/mm3, and CSF protein greater than 300 mg/dl (P less than or equal to 0.05). These data indicate that, although mortality from group B streptococcal meningitis has declined, approximately half of the survivors of acute infection have some degree of morbidity when evaluated at ages permitting the detection of language delay and borderline or mild mental retardation.

Entities:  

Mesh:

Year:  1985        PMID: 3889248     DOI: 10.1016/s0022-3476(85)80342-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  38 in total

1.  Long term outcome of neonatal meningitis.

Authors:  J P Stevens; M Eames; A Kent; S Halket; D Holt; D Harvey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

2.  Oxidative stress, cytokine/chemokine and disruption of blood-brain barrier in neonate rats after meningitis by Streptococcus agalactiae.

Authors:  Tatiana Barichello; Joelson C Lemos; Jaqueline S Generoso; Andreza L Cipriano; Graziele L Milioli; Danielle M Marcelino; Francieli Vuolo; Fabricia Petronilho; Felipe Dal-Pizzol; Márcia Carvalho Vilela; Antonio Lucio Teixeira
Journal:  Neurochem Res       Date:  2011-06-03       Impact factor: 3.996

Review 3.  Early identification of neuro-developmental disorders.

Authors:  P D Singhi
Journal:  Indian J Pediatr       Date:  1992 Jan-Feb       Impact factor: 1.967

4.  Functional analysis of the CpsA protein of Streptococcus agalactiae.

Authors:  Brett R Hanson; Donna L Runft; Cale Streeter; Abhin Kumar; Thomas W Carion; Melody N Neely
Journal:  J Bacteriol       Date:  2012-01-27       Impact factor: 3.490

Review 5.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 6.  Neonatal brain infections.

Authors:  Jacques F Schneider
Journal:  Pediatr Radiol       Date:  2011-04-27

7.  Importance of strain lineages for Group B streptococcal survival.

Authors:  Bryan M Hancock; Kelly S Doran
Journal:  Virulence       Date:  2016-12-29       Impact factor: 5.882

8.  Are newborns morally different from older children?

Authors:  Annie Janvier; Karen Lynn Bauer; John D Lantos
Journal:  Theor Med Bioeth       Date:  2007

Review 9.  Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies.

Authors:  Rogier C J de Jonge; A Marceline van Furth; Merel Wassenaar; Reinoud J B J Gemke; Caroline B Terwee
Journal:  BMC Infect Dis       Date:  2010-08-05       Impact factor: 3.090

10.  Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation.

Authors:  Pia S Pannaraj; Morven S Edwards; Kristen T Ewing; Amanda L Lewis; Marcia A Rench; Carol J Baker
Journal:  Vaccine       Date:  2009-05-31       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.